- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06319716
Utnytte videoer og helsearbeidere i samfunnet for å adressere sosiale helsedeterminanter hos innvandrere (LINK-IT)
LINK-IT: Bruk av videoer og helsearbeidere i samfunnet for å adressere sosiale helsedeterminanter hos innvandrere
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Lu Hu, PhD
- Telefonnummer: 646-501-3438
- E-post: Lu.hu@nyulangone.org
Studiesteder
-
-
New York
-
New York, New York, Forente stater, 10016
- Rekruttering
- NYU Langone Health
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inklusjonskriterier:
- identifisere seg som en kinesisk innvandrer;
- være mellom 18-70 år;
- ha en diagnose type 2 diabetes (T2D) i journalen;
- har hatt en avtale med en lege for rutinemessig T2D-behandling i løpet av de siste 12 månedene;
- har en siste HbA1c på minst 8 %;
- være villig til å motta korte videoer angående T2D-administrasjon; og
- ha en smarttelefon eller, hvis de ikke har en, være villige og i stand til å bruke en studiesmarttelefon.
Ekskluderingskriterier:
- ute av stand til eller villige til å gi informert samtykke;
- ute av stand til å delta meningsfullt i intervensjonen (f.eks. ukorrigert syn og hørselshemming);
- uvillig til å godta randomiseringsoppdrag;
- er gravid, planlegger å bli gravid i løpet av de neste 6 månedene, eller blir gravid i løpet av studien; eller
- er amming (de kan for eksempel ha potensielle kostholdsbegrensninger).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: VIDEO
Deltakere som er tildelt VIDEO-armen vil motta en kort Diabetes Self-Management Education and Support (DSMES) video per uke i 24 uker.
Videoene vil bli levert via tekstmelding.
|
DSMES-videoene gir viktig diabetesopplæring til deltakerne og styrker dem til å bli en aktivert pasient på individnivå.
|
|
Eksperimentell: VIDEO+CHW
Deltakere som er tildelt VIDEO+CHW-armen vil motta en kort DSMES-video per uke, i tillegg til bi-ukentlige støtteanrop fra en samfunnshelsearbeider (CHW), i 24 uker.
DSMES-videoene vil bli levert via tekstmelding.
|
DSMES-videoene gir viktig diabetesopplæring til deltakerne og styrker dem til å bli en aktivert pasient på individnivå.
CHWs vil vurdere deltakernes sosiale determinanter for helse (SDOH) barrierer for type 2 diabetesbehandling og knytte dem til tilgjengelige ressurser i samfunnet.
|
|
Ingen inngripen: CONTROL
Participants assigned to the CONTROL group will continue to receive usual care.
At the end of the study, they will receive DSMES videos.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Hemoglobin A1c (HbA1c) nivåer
Tidsramme: Grunnlinje
|
Grunnlinje
|
|
Hemoglobin A1c (HbA1c) nivåer
Tidsramme: Måned 6
|
Måned 6
|
|
Hemoglobin A1c (HbA1c) nivåer
Tidsramme: Måned 12
|
Måned 12
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
International Physical Activity Questionnaire (IPAQ) kortversjonspoeng
Tidsramme: Grunnlinje
|
Selvevaluering gir et estimat på antall minutter per uke deltakere deltar i tre kategorier fysisk aktivitet: kraftig aktivitet, moderat aktivitet og gåaktivitet. Resultatene er uttrykt i metabolsk ekvivalent (MET) minutter per uke. MET-minutter representerer mengden energi som brukes på å utføre fysisk aktivitet. Formelen for å beregne MET er som følger: 8(kraftig aktivitet)(minutter) + 4 (moderat aktivitet)(minutter) +3,3 (gåaktivitet) (minutter) = MET. Høyere MET-score indikerer høyere ukentlige nivåer av fysisk aktivitet. |
Grunnlinje
|
|
International Physical Activity Questionnaire (IPAQ) kortversjonspoeng
Tidsramme: Måned 6
|
Selvevaluering gir et estimat på antall minutter per uke deltakere deltar i tre kategorier fysisk aktivitet: kraftig aktivitet, moderat aktivitet og gåaktivitet. Resultatene er uttrykt i metabolsk ekvivalent (MET) minutter per uke. MET-minutter representerer mengden energi som brukes på å utføre fysisk aktivitet. Formelen for å beregne MET er som følger: 8(kraftig aktivitet)(minutter) + 4 (moderat aktivitet)(minutter) +3,3 (gåaktivitet) (minutter) = MET. Høyere MET-score indikerer høyere ukentlige nivåer av fysisk aktivitet. |
Måned 6
|
|
International Physical Activity Questionnaire (IPAQ) kortversjonspoeng
Tidsramme: Måned 12
|
Selvevaluering gir et estimat på antall minutter per uke deltakere deltar i tre kategorier fysisk aktivitet: kraftig aktivitet, moderat aktivitet og gåaktivitet. Resultatene er uttrykt i metabolsk ekvivalent (MET) minutter per uke. MET-minutter representerer mengden energi som brukes på å utføre fysisk aktivitet. Formelen for å beregne MET er som følger: 8(kraftig aktivitet)(minutter) + 4 (moderat aktivitet)(minutter) +3,3 (gåaktivitet) (minutter) = MET. Høyere MET-score indikerer høyere ukentlige nivåer av fysisk aktivitet. |
Måned 12
|
|
Stanford Self-Efficacy for Diabetes Scale Score
Tidsramme: Baseline
|
8-item self-assessment of participants' confidence level in performing specific self-management behaviors.
Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The total score can be calculated by summing the 8 item scores (range, 8-80), with higher scores indicating greater self-efficacy.
|
Baseline
|
|
Stanford Self-Efficacy for Diabetes Scale Score
Tidsramme: Month 6
|
8-item self-assessment of participants' confidence level in performing specific self-management behaviors.
Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The total score can be calculated by summing the 8 item scores (range, 8-80), with higher scores indicating greater self-efficacy.
|
Month 6
|
|
Stanford Self-Efficacy for Diabetes Scale Score
Tidsramme: Month 12
|
8-item self-assessment of participants' confidence level in performing specific self-management behaviors.
Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).
The total score can be calculated by summing the 8 item scores (range, 8-80), with higher scores indicating greater self-efficacy.
|
Month 12
|
|
Starting the Conversation (STC) Diet Scale Score
Tidsramme: Baseline
|
8-item self-report questionnaire measuring dietary behaviors.
Scores range from 0 to 16; lower scores indicate healthier eating behaviors.
|
Baseline
|
|
Starting the Conversation (STC) Diet Scale Score
Tidsramme: Month 6
|
8-item self-report questionnaire measuring dietary behaviors.
Scores range from 0 to 16; lower scores indicate healthier eating behaviors.
|
Month 6
|
|
Starting the Conversation (STC) Diet Scale Score
Tidsramme: Month 12
|
8-item self-report questionnaire measuring dietary behaviors.
Scores range from 0 to 16; lower scores indicate healthier eating behaviors.
|
Month 12
|
|
Adherence to Refills and Medications Scale for Diabetes (ARMS-D)
Tidsramme: Baseline
|
ARMS-D is an 11-item questionnaire used to assess medication-taking adherence at baseline, 6 months, and 12 months.
Responses range from 1 ("none of the time") to 4 ("all of the time").
Item scores are summed to produce an overall adherence score ranging from 11 to 44, with higher scores indicating more problems with medication adherence.
|
Baseline
|
|
Adherence to Refills and Medications Scale for Diabetes (ARMS-D)
Tidsramme: Month 6
|
ARMS-D is an 11-item questionnaire used to assess medication-taking adherence at baseline, 6 months, and 12 months.
Responses range from 1 ("none of the time") to 4 ("all of the time").
Item scores are summed to produce an overall adherence score ranging from 11 to 44, with higher scores indicating more problems with medication adherence.
|
Month 6
|
|
Adherence to Refills and Medications Scale for Diabetes (ARMS-D)
Tidsramme: Month 12
|
ARMS-D is an 11-item questionnaire used to assess medication-taking adherence at baseline, 6 months, and 12 months.
Responses range from 1 ("none of the time") to 4 ("all of the time").
Item scores are summed to produce an overall adherence score ranging from 11 to 44, with higher scores indicating more problems with medication adherence.
|
Month 12
|
|
Emotional Support Subscale from the NIH Toolbox Adult Social Relationship Scales
Tidsramme: Baseline
|
8-item subscale to assess individuals' perceptions of empathy and understanding received from others in their social network at baseline, 6 months, and 12 months.
|
Baseline
|
|
Emotional Support Subscale from the NIH Toolbox Adult Social Relationship Scales
Tidsramme: Month 6
|
8-item subscale to assess individuals' perceptions of empathy and understanding received from others in their social network at baseline, 6 months, and 12 months.
|
Month 6
|
|
Emotional Support Subscale from the NIH Toolbox Adult Social Relationship Scales
Tidsramme: Month 12
|
8-item subscale to assess individuals' perceptions of empathy and understanding received from others in their social network at baseline, 6 months, and 12 months.
|
Month 12
|
|
Diabetes-Related Distress
Tidsramme: Baseline
|
Diabetes-related distress will be assessed using the 2-item Diabetes Distress Screening Scale (DDS-2), a validated screening instrument that measures the emotional burden and stress associated with living with diabetes.
Each item is rated on a 6-point Likert scale (1 = "Not a problem" to 6 = "A very serious problem").
The overall score is calculated as the mean of the two items, with higher scores indicating greater diabetes-related distress.
|
Baseline
|
|
Diabetes-Related Distress
Tidsramme: Month 6
|
Diabetes-related distress will be assessed using the 2-item Diabetes Distress Screening Scale (DDS-2), a validated screening instrument that measures the emotional burden and stress associated with living with diabetes.
Each item is rated on a 6-point Likert scale (1 = "Not a problem" to 6 = "A very serious problem").
The overall score is calculated as the mean of the two items, with higher scores indicating greater diabetes-related distress.
|
Month 6
|
|
Diabetes-Related Distress
Tidsramme: Month 12
|
Diabetes-related distress will be assessed using the 2-item Diabetes Distress Screening Scale (DDS-2), a validated screening instrument that measures the emotional burden and stress associated with living with diabetes.
Each item is rated on a 6-point Likert scale (1 = "Not a problem" to 6 = "A very serious problem").
The overall score is calculated as the mean of the two items, with higher scores indicating greater diabetes-related distress.
|
Month 12
|
|
SDOH Barriers
Tidsramme: Baseline
|
The 14-item SDOH questionnaire assessed core health-related barriers across five domains: economic stability (e.g., food access and housing stability), education access and quality (e.g., need to improve English proficiency, reading skills, or educational attainment), health care access and quality (e.g., insurance coverage), neighborhood and built environment (e.g., housing conditions), and social and community context (e.g., racial discrimination; need for childcare; and need for assistance addressing tobacco, alcohol, or drug use).
Items used dichotomous response options (1 = "Yes"; 0 = "No").
An overall SDOH score was calculated by summing responses across the 14 items (range: 0-14), with higher scores indicating greater SDOH-related barriers.
|
Baseline
|
|
SDOH Barriers
Tidsramme: Month 6
|
The 14-item SDOH questionnaire assessed core health-related barriers across five domains: economic stability (e.g., food access and housing stability), education access and quality (e.g., need to improve English proficiency, reading skills, or educational attainment), health care access and quality (e.g., insurance coverage), neighborhood and built environment (e.g., housing conditions), and social and community context (e.g., racial discrimination; need for childcare; and need for assistance addressing tobacco, alcohol, or drug use).
Items used dichotomous response options (1 = "Yes"; 0 = "No").
An overall SDOH score was calculated by summing responses across the 14 items (range: 0-14), with higher scores indicating greater SDOH-related barriers.
|
Month 6
|
|
SDOH Barriers
Tidsramme: Month 12
|
The 14-item SDOH questionnaire assessed core health-related barriers across five domains: economic stability (e.g., food access and housing stability), education access and quality (e.g., need to improve English proficiency, reading skills, or educational attainment), health care access and quality (e.g., insurance coverage), neighborhood and built environment (e.g., housing conditions), and social and community context (e.g., racial discrimination; need for childcare; and need for assistance addressing tobacco, alcohol, or drug use).
Items used dichotomous response options (1 = "Yes"; 0 = "No").
An overall SDOH score was calculated by summing responses across the 14 items (range: 0-14), with higher scores indicating greater SDOH-related barriers.
|
Month 12
|
|
Health-Related Social Needs
Tidsramme: Baseline
|
Health-related social needs (HRSNs) will be assessed using the 26-item The Accountable Health Communities Health-Related Social Needs Screening Tool.
The instrument assesses unmet health-related social needs across 13 domains, including housing instability, food insecurity, transportation needs, utility assistance needs, interpersonal safety, financial strain, employment, family and community support, education, physical activity, substance use, mental health, and disability.
These domains identify social needs that may be addressed through clinical and community-based services.
Each domain includes its own set of indicators.
Descriptive statistics will be used to summarize the data, with frequencies and percentages reported for categorical variables.
For domains with continuous or summed measures, composite scores will be calculated by summing the relevant items, with higher scores indicating greater unmet health-related social needs.
|
Baseline
|
|
Health-Related Social Needs
Tidsramme: Month 6
|
Health-related social needs (HRSNs) will be assessed using the 26-item The Accountable Health Communities Health-Related Social Needs Screening Tool.
The instrument assesses unmet health-related social needs across 13 domains, including housing instability, food insecurity, transportation needs, utility assistance needs, interpersonal safety, financial strain, employment, family and community support, education, physical activity, substance use, mental health, and disability.
These domains identify social needs that may be addressed through clinical and community-based services.
Each domain includes its own set of indicators.
Descriptive statistics will be used to summarize the data, with frequencies and percentages reported for categorical variables.
For domains with continuous or summed measures, composite scores will be calculated by summing the relevant items, with higher scores indicating greater unmet health-related social needs.
|
Month 6
|
|
Health-Related Social Needs
Tidsramme: Month 12
|
Health-related social needs (HRSNs) will be assessed using the 26-item The Accountable Health Communities Health-Related Social Needs Screening Tool.
The instrument assesses unmet health-related social needs across 13 domains, including housing instability, food insecurity, transportation needs, utility assistance needs, interpersonal safety, financial strain, employment, family and community support, education, physical activity, substance use, mental health, and disability.
These domains identify social needs that may be addressed through clinical and community-based services.
Each domain includes its own set of indicators.
Descriptive statistics will be used to summarize the data, with frequencies and percentages reported for categorical variables.
For domains with continuous or summed measures, composite scores will be calculated by summing the relevant items, with higher scores indicating greater unmet health-related social needs.
|
Month 12
|
|
Cognitive Function
Tidsramme: Baseline
|
Cognitive function will be assessed using the Mini-Montreal Cognitive Assessment (Mini-MoCA), a validated 15-point screening instrument for the rapid detection of mild cognitive impairment.
Total scores range from 0 to 15, with higher scores indicating better cognitive function.
A score below 11 may indicate cognitive impairment and warrant further evaluation.
|
Baseline
|
|
Cognitive Function
Tidsramme: Month 6
|
Cognitive function will be assessed using the Mini-Montreal Cognitive Assessment (Mini-MoCA), a validated 15-point screening instrument for the rapid detection of mild cognitive impairment.
Total scores range from 0 to 15, with higher scores indicating better cognitive function.
A score below 11 may indicate cognitive impairment and warrant further evaluation.
|
Month 6
|
|
Cognitive Function
Tidsramme: Month 12
|
Cognitive function will be assessed using the Mini-Montreal Cognitive Assessment (Mini-MoCA), a validated 15-point screening instrument for the rapid detection of mild cognitive impairment.
Total scores range from 0 to 15, with higher scores indicating better cognitive function.
A score below 11 may indicate cognitive impairment and warrant further evaluation.
|
Month 12
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Lu Hu, PhD, NYU Langone Health
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sykdommer i det endokrine systemet
- Metabolske sykdommer
- Glukosemetabolismeforstyrrelser
- Sukkersyke
- Ernæringsmessige og metabolske sykdommer
- Diabetes mellitus, type 2
- Terapeutikk
- Pasientbehandling
- Helsetjenester
- Helsetjenester arbeidsstyrke og tjenester
- Helsepersonell
- Alliert helsepersonell
- Palliativ omsorg
- Fellesskapets helsearbeidere
Andre studie-ID-numre
- 23-01274
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .